Patents by Inventor Tamara Smokvina

Tamara Smokvina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241357
    Abstract: The present invention relates to a composition comprising L. rhamnosus CNCM I-3690 for use in prevention, amelioration or treatment of anxiety and/or psychological stress in an individual.
    Type: Application
    Filed: June 12, 2020
    Publication date: August 4, 2022
    Inventors: Tamara SMOKVINA, Raphaël MORIEZ, Jan TACK, Lukas VAN OUDENHOVE, Tim VANUYTSEL, Lucas WAUTERS
  • Patent number: 11207358
    Abstract: The present invention relates to a composition comprising a given Lactobacillus rhamnosus strain and a given Lactobacillus paracasei strain wherein the ratio of the given Lactobacillus rhamnosus strain to the given Lactobacillus paracasei strain (LR?:LP?) is higher or equal to 8:1 and to methods thereof.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: December 28, 2021
    Assignee: COMPAGNIE GERVAIS DANONE
    Inventors: Tamara Smokvina, Rebeca Martin Rosique, Philippe Langella
  • Publication number: 20200140806
    Abstract: The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.
    Type: Application
    Filed: November 6, 2019
    Publication date: May 7, 2020
    Applicants: LONDON HEALTH SCIENCES CENTRE RESEARCH INC., COMPAGNIE GERVAIS DANONE
    Inventors: Jordan BISANZ, Gregor REID, Marc MONACHESE, Johan VAN HYLCKAMA VLEIG, Tamara SMOKVINA, Jeremy BURTON
  • Publication number: 20200078420
    Abstract: The present invention relates to a composition comprising a given Lactobacillus rhamnosus strain and a given Lactobacillus paracasei strain wherein the ratio of said given Lactobacillus rhamnosus strain to said given Lactobacillus paracasei strain (LR?:LP?) is higher or equal to 8:1.
    Type: Application
    Filed: December 16, 2016
    Publication date: March 12, 2020
    Inventors: Tamara SMOKVINA, Rebeca MARTIN ROSIQUE, Philippe LANGELLA
  • Patent number: 10487305
    Abstract: The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: November 26, 2019
    Assignees: LONDON HEALTH SCIENCES CENTRE RESEARCH INC., COMPAGNIE GERVAIS DANONE
    Inventors: Jordan Bisanz, Gregor Reid, Marc Monachese, Johan Van Hylckama Vlieg, Tamara Smokvina, Jeremy Burton
  • Patent number: 10184127
    Abstract: The present invention concerns a method for genetically transforming a Bifidobacterium strain comprising a step of methylation of a shuttle vector in an E. coli or a Gram-positive bacterium strain by two type II DNA methyltransferases from a Bifidobacterium: a methyltransferase enzyme that methylates the adenine base at position 4 of the nucleotide sequence RTCAGG and a methyltransferase enzyme that methylates the cytosine base at position 4 of the nucleotide sequence GGWCC. The present invention also concerns genetic tools and culture media useful for carrying out said method.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: January 22, 2019
    Assignees: Compagnie Gervais Danone, University College Cork—National University of Ireland, Cork
    Inventors: Douwe van Sinderen, Mary O'Connell Motherway, Debbie Watson, Tamara Smokvina, Peggy Garault
  • Patent number: 10064902
    Abstract: The invention relates to a novel strain of Bifidobacterium animals ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: September 4, 2018
    Assignee: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Patent number: 9540609
    Abstract: The present invention relates to food-grade bacteria strain being capable of removing mercury from an aqueous environment.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: January 10, 2017
    Inventors: Jeremy Burton, Marc Monaches, Gregor Reid, Tamara Smokvina, Johan Van Hylckama Vlieg, Jordan Bisanz
  • Publication number: 20160304885
    Abstract: The present invention concerns a method for genetically transforming a Bifidobacterium strain comprising a step of methylation of a shuttle vector in an E. coli or a Gram-positive bacterium strain by two type II DNA methyltransferases from a Bifidobacterium: a methyltransferase enzyme that methylates the adenine base at position 4 of the nucleotide sequence RTCAGG and a methyltransferase enzyme that methylates the cytosine base at position 4 of the nucleotide sequence GGWCC. The present invention also concerns genetic tools and culture media useful for carrying out said method.
    Type: Application
    Filed: December 2, 2013
    Publication date: October 20, 2016
    Applicants: Compagnie Gervais Danone, University College Cork - National University of Ireland, Cork
    Inventors: Douwe van Sinderen, Mary O'Connell Motherway, Debbie Watson, Tamara Smokvina, Peggy Garault
  • Patent number: 9297049
    Abstract: The invention relates to a new strain of Lactobacillus mucosae which is able to decrease intestinal barrier permeability. This strain is useful in particular for alleviating intestinal barrier dysfunctions.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: March 29, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Tamara Smokvina, Marie-Christine Degivry
  • Publication number: 20160074444
    Abstract: The invention relates to the use of a strain of Lactobacillus rhamnosus for preventing or treating pathologies associated with an excessive accumulation of body fat. This strain is preferably administered orally, in particular in the form of a food or a food supplement.
    Type: Application
    Filed: April 18, 2014
    Publication date: March 17, 2016
    Applicants: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, COMPAGNIE GERVAIS DANONE
    Inventors: Elsa Jacouton, Hervé Blottiére, Tamara Smokvina, Joel Doré, Johan Van Hylckama Vlieg
  • Publication number: 20160045557
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 18, 2016
    Applicant: COMPAGNE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Patent number: 9198940
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: December 1, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Publication number: 20150320807
    Abstract: The invention relates to a novel strain of Bifidobacterium animals ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.
    Type: Application
    Filed: December 10, 2013
    Publication date: November 12, 2015
    Inventors: Sophie LEGRAIN-RASPAUD, Gianfranco GROMPONE, Sandrine CAPRONNIER, Tamara SMOKVINA, Marie-Christine DEGIVRY, Biliana LESIC, Michel NEUNLIST
  • Publication number: 20150191691
    Abstract: The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.
    Type: Application
    Filed: April 5, 2013
    Publication date: July 9, 2015
    Applicants: LONDON HEALTH SCIENCES CENTRE RESEARCH INC., COMPAGNIE GERVAIS DANONE
    Inventors: Jordan Bisanz, Gregor Reid, Marc Monachese, Johan Van Hylckama Vlieg, Tamara Smokvina, Jeremy Burton
  • Publication number: 20150079236
    Abstract: The present invention relates to food-grade bacteria strain being capable of removing mercury from an aqueous environment.
    Type: Application
    Filed: April 5, 2013
    Publication date: March 19, 2015
    Inventors: Jeremy Burton, Marc Monaches, Gregor Reid, Tamara Smokvina, Johan Van Hylckama Vlieg
  • Publication number: 20140328802
    Abstract: The invention relates to a new strain of Lactobacillus mucosae which is able to decrease intestinal barrier permeability. This strain is useful in particular for alleviating intestinal barrier dysfunctions.
    Type: Application
    Filed: December 21, 2011
    Publication date: November 6, 2014
    Inventors: Tamara Smokvina, Marie-Christine Degivry
  • Publication number: 20140294791
    Abstract: The present invention relates to the use of the probiotic strain of Lactobacillus paracasei subsp. paracasei deposited at the CNCM under the reference I-3689, for inhibiting in vivo infection by Listeria monocytogenes.
    Type: Application
    Filed: December 1, 2011
    Publication date: October 2, 2014
    Applicants: INSTITUT PASTEUR, COMPAGNIE GERVAIS DANONE
    Inventors: Tamara Smokvina, Gianfranco Grompone, Sophie Legrain-Raspaud, Cristel Archambaud, Marc Lecuit, Pascale Cossart
  • Patent number: 8557561
    Abstract: The invention relates to a novel strain of Lactobacillus paracasei subspecies paracasei, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: October 15, 2013
    Assignee: Compagnie Gervais Danone
    Inventors: Isabelle Chambaud, Artem Khlebnikov, Anne-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis, Anne Druesne, Tamara Smokvina
  • Publication number: 20130195822
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: May 27, 2011
    Publication date: August 1, 2013
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist